Gary M. Phillips

Gary M. Phillips, M.D. has served as OrphoMed’s President and Chief Executive Officer since April 2018. Dr. Phillips has over two decades of experience in the pharmaceutical and healthcare industries, leading commercial operations, clinical medicine, business strategy, and development functions. Before joining OrphoMed, Dr. Phillips worked with Mallinckrodt Pharmaceuticals, where he served as Executive Vice President and Chief Strategy Officer since 2013. Previously, he was Head of Global Health & Healthcare Industries at the World Economic Forum. Earlier, he served as President of Reckitt Benckiser Pharmaceuticals North America (now Indivior), and he held dual roles as President, U.S. Surgical and Pharmaceuticals, and Global Head of Pharmaceuticals at Bausch & Lomb. Additionally, he has served in executive roles at Merck Serono, Novartis, and Wyeth. From the University of Pennsylvania, he earned a B.A. in Biochemistry with Summa Cum Laude and Phi Beta Kappa distinctions from the College of Arts and Sciences, an MBA from the Wharton School, and an M.D. with Alpha Omega Alpha distinction from the School of Medicine. Dr. Phillips maintains an active medical license and practiced as a general medicine clinician/officer in the U.S. Navy, from which he was honorably discharged as a lieutenant commander.